Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
viral vectors
Biotech
Neurogene details death in Rett syndrome gene therapy trial
The biotech recommends using lower AAV doses and monitoring patients for the serious inflammatory condition that caused the patient's death.
Darren Incorvaia
May 16, 2025 3:00pm
Vertex discontinues AAV research for gene therapies
May 2, 2025 6:22pm
Ring lays off nearly half of staff, CEO to exit in new year
Dec 18, 2024 2:31pm
GSK axes hepatitis B vaccine trial after missing efficacy goal
Dec 4, 2024 5:15am
Ring's 'new class of viral vector' is re-dosable in primates
May 8, 2024 5:05pm
Ring's new human viral vector delivers gene to retinas of mice
Apr 2, 2024 8:10am
